Walgreens Boots Alliance, Inc. (NASDAQ:WBA) – Stock analysts at Truist Securiti reduced their FY2021 earnings estimates for Walgreens Boots Alliance in a research note issued on Monday, April 5th. Truist Securiti analyst D. Macdonald now forecasts that the pharmacy operator will earn $4.62 per share for the year, down from their previous estimate of $4.80.
Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Tuesday, March 30th. The pharmacy operator reported $1.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.10 by $0.30. The company had revenue of $32.78 billion for the quarter, compared to the consensus estimate of $36.16 billion. Walgreens Boots Alliance had a return on equity of 18.33% and a net margin of 0.33%. Walgreens Boots Alliance’s revenue was down 8.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.52 EPS.
WBA opened at $55.58 on Thursday. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.32 and a current ratio of 0.67. The stock has a market capitalization of $48.02 billion, a PE ratio of 111.16, a price-to-earnings-growth ratio of 1.52 and a beta of 0.44. The stock’s 50 day moving average price is $51.08 and its 200-day moving average price is $43.77. Walgreens Boots Alliance has a 52-week low of $33.36 and a 52-week high of $57.05.
Institutional investors have recently made changes to their positions in the stock. Aristotle Capital Management LLC lifted its stake in shares of Walgreens Boots Alliance by 7.9% during the 4th quarter. Aristotle Capital Management LLC now owns 8,545,932 shares of the pharmacy operator’s stock valued at $339,010,000 after buying an additional 628,230 shares in the last quarter. Bank of New York Mellon Corp raised its position in shares of Walgreens Boots Alliance by 3.6% during the fourth quarter. Bank of New York Mellon Corp now owns 8,313,083 shares of the pharmacy operator’s stock valued at $331,525,000 after buying an additional 285,867 shares during the last quarter. Norges Bank purchased a new stake in Walgreens Boots Alliance during the fourth quarter valued at approximately $312,858,000. Dimensional Fund Advisors LP lifted its stake in shares of Walgreens Boots Alliance by 1.3% in the 4th quarter. Dimensional Fund Advisors LP now owns 7,685,947 shares of the pharmacy operator’s stock valued at $306,475,000 after purchasing an additional 96,061 shares during the last quarter. Finally, American International Group Inc. boosted its stake in Walgreens Boots Alliance by 20.9% during the fourth quarter. American International Group Inc. now owns 4,973,586 shares of the pharmacy operator’s stock worth $198,347,000 after buying an additional 858,595 shares during the period. 55.96% of the stock is currently owned by institutional investors.
The business also recently disclosed a quarterly dividend, which was paid on Friday, March 12th. Stockholders of record on Friday, February 19th were paid a $0.4675 dividend. The ex-dividend date was Thursday, February 18th. This represents a $1.87 annualized dividend and a dividend yield of 3.36%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is 39.45%.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and beauty retail company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.
Featured Story: What are the benefits of a portfolio tracker?
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.